Furthermore, EZH2 GOF is closely associated with epigenetic silencing of CD58 expression on lymphoma cells, thus blocking the interaction with cytotoxic effector CD2+ T and NK cells and interrupting another avenue of immune control (Figure 2) (Otsuka et al., 2020). This evidence concerns the gene EZH2 and lymphoma.